In 2012, a landmark study of 4 patients with mRCC showed marked intratumoral genomic heterogeneity by tissue based NGS for multiple tumor suppressor genes relevant to RCC, including SETD2, MTOR, KDM5C and PTEN [14]. This evidence concerns the gene SETD2 and renal cell carcinoma.